Advisory Services Network’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.52M | Sell |
45,737
-6,598
| -13% | -$358K | 0.03% | 551 |
|
|
2025
Q4 | $2.57M | Sell |
52,335
-1,856
| -3% | -$86.6K | 0.04% | 512 |
|
|
2025
Q3 | $2.34M | Sell |
54,191
-21,567
| -28% | -$842K | 0.03% | 529 |
|
|
2025
Q2 | $2.81M | Sell |
75,758
-6,374
| -8% | -$244K | 0.05% | 438 |
|
|
2025
Q1 | $3.18M | Buy |
82,132
+999
| +1% | +$36.6K | 0.06% | 360 |
|
|
2024
Q4 | $2.74M | Buy |
81,133
+650
| +0.8% | +$23.4K | 0.05% | 402 |
|
|
2024
Q3 | $3.1M | Hold |
80,483
| – | – | 0.06% | 326 |
|
|
2024
Q2 | $3.1M | Sell |
80,483
-7,046
| -8% | -$296K | 0.06% | 326 |
|
|
2024
Q1 | $3.75M | Buy |
87,529
+19,320
| +28% | +$797K | 0.08% | 273 |
|
|
2023
Q4 | $2.53M | Sell |
68,209
-2,513
| -4% | -$90.2K | 0.06% | 367 |
|
|
2023
Q3 | $2.56M | Buy |
70,722
+16,233
| +30% | +$576K | 0.07% | 334 |
|
|
2023
Q2 | $1.94M | Sell |
54,489
-5,818
| -10% | -$209K | 0.05% | 418 |
|
|
2023
Q1 | $2.15M | Sell |
60,307
-1,631
| -3% | -$57.1K | 0.06% | 385 |
|
|
2022
Q4 | $2.18M | Sell |
61,938
-13,973
| -18% | -$465K | 0.07% | 349 |
|
|
2022
Q3 | $2.23M | Buy |
75,911
+34,437
| +83% | +$1.31M | 0.08% | 299 |
|
|
2022
Q2 | $2.26M | Sell |
41,474
-20,327
| -33% | -$1.12M | 0.08% | 308 |
|
|
2022
Q1 | $3.37M | Buy |
61,801
+11,227
| +22% | +$610K | 0.1% | 242 |
|
|
2021
Q4 | $2.79M | Buy |
50,574
+16,499
| +48% | +$858K | 0.08% | 299 |
|
|
2021
Q3 | $1.63M | Buy |
34,075
+14,181
| +71% | +$712K | 0.05% | 439 |
|
|
2021
Q2 | $990K | Buy |
19,894
+2,384
| +14% | +$115K | 0.03% | 593 |
|
|
2021
Q1 | $781K | Buy |
17,510
+10,029
| +134% | +$455K | 0.03% | 652 |
|
|
2020
Q4 | $344K | Buy |
7,481
+219
| +3% | +$10.1K | 0.01% | 884 |
|
|
2020
Q3 | $341K | Buy |
7,262
+1,092
| +18% | +$54.7K | 0.02% | 778 |
|
|
2020
Q2 | $315K | Buy |
6,170
+23
| +0.4% | +$1.18K | 0.02% | 771 |
|
|
2020
Q1 | $292K | Buy |
6,147
+319
| +5% | +$17K | 0.02% | 685 |
|
|
2019
Q4 | $342K | Buy |
5,828
+848
| +17% | +$47.2K | 0.02% | 731 |
|
|
2019
Q3 | $249K | Hold |
4,980
| – | – | 0.02% | 762 |
|
|
2019
Q2 | $249K | Sell |
4,980
-1,595
| -24% | -$80K | 0.02% | 760 |
|
|
2019
Q1 | $343K | Sell |
6,575
-834
| -11% | -$41.7K | 0.02% | 619 |
|
|
2018
Q4 | $353K | Sell |
7,409
-87
| -1% | -$4.29K | 0.03% | 545 |
|
|
2018
Q3 | $376K | Sell |
7,496
-3,794
| -34% | -$193K | 0.03% | 588 |
|
|
2018
Q2 | $570K | Sell |
11,290
-832
| -7% | -$41.9K | 0.04% | 478 |
|
|
2018
Q1 | $592K | Sell |
12,122
-1,003
| -8% | -$46.7K | 0.05% | 479 |
|
|
2017
Q4 | $582K | Buy |
13,125
+9,843
| +300% | +$455K | 0.05% | 435 |
|
|
2017
Q3 | $167K | Buy |
3,282
+44
| +1% | +$2.23K | 0.02% | 709 |
|
|
2017
Q2 | $175K | Buy |
3,238
+631
| +24% | +$33.6K | 0.02% | 665 |
|
|
2017
Q1 | $137K | Buy |
+2,607
| New | +$132K | 0.02% | 718 |
|
|
2016
Q3 | $163K | Buy |
3,014
+421
| +16% | +$23.1K | 0.03% | 556 |
|
|
2016
Q2 | $140K | Sell |
2,593
-641
| -20% | -$33.8K | 0.03% | 530 |
|
|
2016
Q1 | $164K | Sell |
3,234
-255
| -7% | -$12.7K | 0.04% | 417 |
|
|
2015
Q4 | $176K | Sell |
3,489
-591
| -14% | -$30.1K | 0.06% | 351 |
|
|
2015
Q3 | $196K | Buy |
4,080
+1,080
| +36% | +$56.2K | 0.06% | 280 |
|
|
2015
Q2 | $157K | Buy |
3,000
+662
| +28% | +$37.3K | 0.05% | 312 |
|
|
2015
Q1 | $137K | Sell |
2,338
-22
| -0.9% | -$1.26K | 0.04% | 333 |
|
|
2014
Q4 | $130K | Sell |
2,360
-6,496
| -73% | -$363K | 0.04% | 291 |
|
|
2014
Q3 | $509K | Buy |
8,856
+662
| +8% | +$40.6K | 0.19% | 134 |
|
|
2014
Q2 | $548K | Buy |
+8,194
| New | +$555K | 0.23% | 112 |
|
|
2014
Q1 | – | Sell |
-2,746
| Closed | -$183K | – | 447 |
|
|
2013
Q4 | $183K | Buy |
+2,746
| New | +$178K | 0.09% | 184 |
|
Other funds holding GSK
JEST
Advisory Services Network's GSK Position: Q1 2026 in Review
Advisory Services Network reduced its GSK (GSK) stake by 13% in Q1 2026, selling an estimated $358K and leaving 45,737 shares worth $2.52M. The position accounts for 0.03% of the portfolio, ranked #551.
Advisory Services Network first reported a position in GSK in Q4 2013 and has held it in 48 quarters since. The position peaked at $3.75M in Q1 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Advisory Services Network held 45,737 shares of GSK worth $2.52M as of Q1 2026.
- Advisory Services Network sold 6,598 GSK shares in Q1 2026, an estimated $358K.
- GSK made up 0.03% of Advisory Services Network's portfolio in Q1 2026, its #551 holding.
- Advisory Services Network first reported a position in GSK in Q4 2013 and has held it in 48 quarters since.
- Advisory Services Network's GSK position peaked at $3.75M in Q1 2024.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.